1 Leon Aarons University of Manchester UK
2 Ann Allen SmithKline Beecham England
3 MAGALI ANDANSON SERVICE DE PHARMACOLOGIE CLINIQUE - Pr BOISSEL FRANCE
4 Bill Bachman GloboMax LLC USA
5 Misba Beerahee GlaxoWellcome UK
6 Pascale Bernillon INSERM France
7 Elisa Berno University of Torino Italy
8 Graham Blakey Astra Charnwood UK
9 Frederic Yves BOIS INSERM France
10 François BOUZOM Technologie Servier France
11 Rene Bruno Rhone-Poulenc Rorer France
12 Samantha Carmichael Imperial Cancer Research Fund UK
13 BRUNO CHARPIAT CROIX-ROUSSE Hospital FRANCE
14 Paul Chevalier Rhône-Poulenc Rorer France
15 Chantal Csajka Division of Clinical Pharmacology Swizerland
16 Marie Cullberg Astra Hassle Sweden
17 Anthony Davison EPFL Switzerland
18 Oscar Della Pasqua GlaxoWellcome Research & Development UK
19 Carlo Della Pepa University of Torino Italy
20 Alfonso Domínguez-Gil Hurlé Universidad de Salamanca España
21 Stephen Duffull University of Manchester UK
22 Mario Eandi University of Torino Italy
23 Karin Fattinger Div. of Clinical Pharmacology, University Hospital Switzerland
24 Agneta Freijs Division of Biopharmaceutics and Pharmacokinetics Sweden
25 Nicolas FREY IRIS France
26 GILLES FREYER Centre Hospitalier Lyon-Sud FRANCE
27 Tomoo Funaki Nippon Roche K.K. Japan
28 Eliane FUSEAU GlaxoWellcome UK
29 Mª José García Sánchez Universidad de Salamanca España
30 Ronald Gieschke F.Hoffmann-La Roche Switzerland
31 Pascal Girard Service Pharmacologie Clinique, EA643 France
32 Carla Gomeni Biotrial France
33 Roberto Gomeni Zeneca Pharma France
34 Gordon Graham University of Manchester UK
35 Lutz Harnisch HMR Germany
36 Tracy Higgins Covance CRU England
37 Nils Ove Hoem University of Oslo Norway
38 Philip Jarvis Zeneca UK
39 Roger Jelliffe USC School of Medicine USA
40 Byron Jones De Montfort University UK
41 Niclas Jonsson Uppsala University Sweden
42 Siv Jonsson Uppsala University, Dep of Pharmacy/Div of Biopharmaceutics and Pharmacokinetics Sweden
43 Fredrik Jonsson National Institute for Working Life Sweden
44 Martin Karlberg Astra Arcus AB Sweden
45 Mats Karlsson Uppsala University Sweden
46 William knebel GloboMax LLC USA
47 Ritu Lal Abbott Laboratories USA
48 Jose M. Lanao University of Salamanca Spain
49 CHRISTIAN LAVEILLE IRIS FRANCE
50 patricia Lefebvre Rhône-Poulenc Rorer France
51 Chantal LE GUELLEC Pharmacology FRANCE
52 Michael Looby Pfizer Limited England
53 Thomas Ludden GloboMax USA
54 Harry Mager Bayer AG Germany
55 Alain Mallet University of paris 6, INSERM france
56 Pierre Maitre Clinique de Genolier Switzerland
57 Scott Marshall Pfizer Limited England
58 jean xavier Mazoit Université Paris-sud France
59 Peter Mccormack ASTRA UK
60 France Mentre INSERM U436 France
61 Yann MERLÉ INSERM U436 FRANCE
62 Peter Milligan Pfizer Limited England
63 Ruth Oliver GloboMax USA
64 Per Olsson GlaxoWellcome R&D UK
65 Gilles PAINTAUD Laboratory of Pharmacology and Toxicology France
66 BELA PATEL SMITHKLINE BEECHAM USA
67 Poul Chr. Pedersen Novo Nordisk A/S Denmark
68 Helen Pentikis GloboMax USA
69 Olivier PETRICOUL GlaxoWellcome R&D ENGLAND
70 Vladimir Piotrovsky Janssen Research Foundation Belgium
71 Maria Pitsiu Medeval Ltd UK
72 christian Pobel C.H. Saintes France
73 Ruedi Port German Cancer Research Center Germany
74 Sylvie Retout Rhone-Poulenc Rorer France
75 Ferdinand Rombout Bayer AG, Business Group Pharma, Institute of Clinical Pharmacology Germany
76 Marie Sandström Dep of Pharmacy, Div. of Biopharmaceutics and Pharmacokinetics Sweden
77 Mª Dolores Santos Buelga Universidad de Salamanca España
78 Hans Schaefer ELI LILLY AND COMPANY UK
79 Norbert Schmidt Bayer AG Germany
80 Rik Schoemaker CHDR Netherlands
81 Jagdev Sidhu SmithKline Beecham U.K.
82 Nicolas Simon Parke-Davis France
83 Lena Simonsen Uppsala University Sweden
84 Guilherme Suarez-Kurtz Instituto Nacional de Cancer, Brazil Brazil
85 Tanigawa Takahiko Bayer Yakuhin,Ltd. Japan
86 Paul Tanswell Boehringer Ingelheim Pharma KG Germany
87 Alison Thomson University of Glasgow Scotland
88 Christiane Tillmann Eli Lilly United Kingdom
89 MICHEL TOD CHU AVICENNE FRANCE
90 Brigitte Tranchand Centre Léon-Bérard France
91 David Tudor Novartis Pharma, AG Switzerland
92 LUC VAN OBBERGH ANESTHESIOLOGY BELGIUM
93 Christine Veyrat-Follet Rhone-Poulenc Rorer France
94 Nicole Vivier Rhone-Poulenc Rorer France
95 Janet Wade MPA Sweden
96 Ulrika Wählby Uppsala University Sweden
97 Jeff Wald Pharsight USA
98 Estelle Watson University of Manchester UK
99 Willi Weber Aventis Hoechst Germany
100 Paul Williams University of the Pacific USA